by Alexis DUPORT | 4 Oct, 2016 | Gènéthique informs you
A “prowess”, a “revolution”, “promises”: one semantic field used to amplify every new announcement –though isolated- concerning work based on human embryonic stem cells. This week, it was the turn of the Californian company Asterias Biotherapeutics, which is...
by Alexis DUPORT | 3 Oct, 2016 | Gènéthique informs you
Yesterday, the Social Affairs Commission of the Parliamentary Assembly of the Council of Europe (PACE) rejected the draft resolution by Petra Sutter (cf. The Council of Europe rejects the report on surrogacy), which underlined the risks of surrogacy for-profit,...
by Alexis DUPORT | 3 Oct, 2016 | Gènéthique informs you
While the Paralympics are coming to an end, another competition, the Cybathlon, is about to bring together disabled people, who will be confronting each other in trials carried out in symbiosis with various technological devices. The Cybathlon, organised in...
by Alexis DUPORT | 21 Jul, 2016 | Gènéthique informs you
On July 21st, 2016, the European Court of Human Rights rendered public its ruling concerning the Foulon and Bouvet cases against France (no 9063/14 and 10410/14) in which the French authorities were accused of refusing to record the filiation...
by Alexis DUPORT | 18 Jul, 2016 | Gènéthique informs you
Naprotechnology: a medical assistance for natural procreation This summer’s news began with our institutions persistently trying to extend the scope of medically assisted procreation[1]. The regular buzz[2] created by the subject leads us to believe that this...
by Alexis DUPORT | 14 Jul, 2016 | Gènéthique informs you
On Monday, Libération published a sensational article: “Le regret d’être mère, ultime tabou” – (The regrets of being a mother, the ultimate taboo)”, highlighting a study [1] that focuses on the phenomenon of regretting motherhood. Thérèse Hargot,...